Zealand Pharma A/S (CPH:ZEAL)
610.00
-53.00 (-7.99%)
Mar 3, 2025, 4:59 PM CET
Zealand Pharma Revenue
In the year 2024, Zealand Pharma had annual revenue of 62.69M DKK, down -81.71%. Zealand Pharma had revenue of 9.06M in the quarter ending December 31, 2024, a decrease of -61.02%.
Revenue
62.69M
Revenue Growth
-81.71%
P/S Ratio
n/a
Revenue / Employee
187.14K
Employees
335
Market Cap
43.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
Coloplast | 27.45B |
Genmab | 21.53B |
Demant | 22.42B |
H. Lundbeck | 22.00B |
Ambu A/S | 5.65B |
ALK-Abelló | 5.54B |
GN Store Nord | 17.99B |
Zealand Pharma News
- 11 days ago - Zealand Pharma targets 15-20% weight loss with petrelintide trials in 2025 - Seeking Alpha
- 11 days ago - Zealand Pharma A/S (ZLDPF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Correction: Zealand Pharma Announces Financial Results for the Full Year 2024 - GlobeNewsWire
- 12 days ago - Zealand Pharma Announces Financial Results for the Full Year 2024 - GlobeNewsWire
- 18 days ago - Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results - GlobeNewsWire
- 6 weeks ago - Zealand CEO on navigating the obesity space among the two biggest players - CNBC
- 7 weeks ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 7 weeks ago - Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity - GlobeNewsWire